| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
First Department of Internal Medicine, Kumamoto University School of Medicine, Kumamoto, Japan; and
Pulmonary Center, Boston University School of Medicine, Boston, MA 02118
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
, and that IL-10 ameliorates
severity of the disease, indicating a Th1-type response. To determine
whether a Th1 phenotype in HP also exists clinically, bronchoalveolar
lavage (BAL) and peripheral blood (PB) T cells were obtained from HP
individuals and analyzed for Th1 vs Th2 cytokine profiles. It was
determined that soluble OKT3-stimulated BAL T cells cocultured with
alveolar macrophages produced more IFN- and less IL-10 than PB T
cells cocultured with monocytes, but no difference was observed in IL-4
production. The monocytic cells did not account for this difference, as
CD80 and CD86 expressions were similar, and coculturing PB T cells with
alveolar macrophages resulted in no difference in IFN- production.
Similarly, there was no difference in IL-12 production between
stimulated BAL or PB T cells; however, addition of rIL-12 significantly
increased production of IFN- by BAL T cells, but not by PB T cells.
This effect was due to a difference in IL-12R expression. High affinity
IL-12R were only present in association with BAL T cells. These studies
indicate that clinical HP is characterized by a predominance of
IFN--producing T cells, perhaps resulting from a reduction in IL-10
production and an increase in high affinity IL-12R compared with blood
T cells. |
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
As mentioned above, one of the most striking pathological features of HP is a remarkable lymphocytosis in the BAL fluid, which is usually comprised predominantly of CD8+ T cells, and therefore, the CD4/CD8 ratio usually drops below 1.0 (16, 17, 18, 19). However, there is an increase in absolute numbers of total T cells, not only CD8+ T cells but CD4+ T cells are also significantly higher in HP patients compared with control or other interstitial lung diseases (20, 21). These findings suggest that both CD4+ and CD8+ T cells found in the lung might contribute to the pathogenesis of HP.
CD4+ and CD8+ T cell
subsets can be characterized by restricted cytokine secretion profiles
(Ref. 22; reviewed in 23), whereby type 1 (e.g.,
CD4+ Th1) cells are defined by a preferential
secretion of IFN- and IL-2, and type 2 (e.g., Th2) cells are defined
by preferential secretion of IL-4, IL-5, and IL-10. Certain diseases
are also characterized, based on the nature and proportion of cytokines
present, as either Th1- or Th2-type diseases. In general, Th1 cytokines
are present in cell-mediated immune responses and appear to be involved
in chronic inflammatory conditions, whereas Th2 cytokines up-regulate
IgE production and are prominent in the pathogenesis of allergic
diseases. The in vivo cross-regulation and significance of the
CD4+ Th1 and Th2 subsets in multiple disease
models and clinical states (reviewed in 24) have been documented
even in lung diseases such as sarcoidosis, characterized by a Th1-type
cytokine-dominant profile (25), and bronchial asthma,
characterized by a Th2-type (26) cytokine profile.
Recent data using animal models of HP have drawn increasing attention
to the importance of Th1-type cytokines and IFN- in particular.
Schuyler et al. (27) reported that a Th1
CD4+ cell line could adoptively transfer
experimental HP in mice, and Cudmundsson et al. (28)
reported, using IFN- knockout mice, that IFN- was essential for
the expression of HP-like disease. While the animal models have clearly
defined HP as a Th1 cell-type disease, clinical studies investigating
cytokine profiles of HP patients have not been reported.
In this study we identify a predominance of IFN--producing T cells
obtained in the bronchoalveolar lavage fluid (BAL T), but not from
peripheral blood-derived T cells (PB T), in HP patients. The potential
mechanism for development of the Th1 profile in HP was investigated by
addressing the endogenous generation of IL-10 and IL-12 cytokines as
well as the effects of exogenous addition of IL-10 and IL-12 on IFN-
production. The contributions of blood monocytes and alveolar
macrophages to this process were also investigated. These studies
indicate, for the first time, a polarized type 1 cytokine profile
associated with the BAL T cells from HP patients and identify factors
that probably contribute to development of this condition.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Six patients, all nonsmokers, were diagnosed with HP according to clinical symptoms, the positive environmental provocation test, the existence of specific Abs, characteristic manifestation in high-resolution computed graphic (HRCT) findings, the typical BAL findings, and the typical clinical course. Three patients were classified as having summer-type hypersensitivity pneumonitis induced by Trichosporon cutaneum, while the remaining three patients were diagnosed as having farmer’s lung. None of these patients was receiving steroid therapy at the time of examination.
Bronchoalveolar lavage and cell preparation
In all cases BAL was performed in the right middle lobe as previously reported (29), using three aliquots (50 ml each) of sterile physiologic saline solution. Immediately after the lavage, the lavage fluid was filtered through gauze into 50-ml conical tubes. The tubes were centrifuged at 150 x g for 5 min at 4°C, and the residual pellets were resuspended and washed three times in RPMI 1640 medium (Life Technologies, Grand Island, NY). The cells were finally suspended in RPMI 1640 supplemented with 10% FBS, 5 x 10-5 M 2-ME, 100 U/ml penicillin, and 100 mg/ml streptomycin. Cellular differentials were performed by cytocentrifugation and stained using a Diff Quick Stain (Hareco, Gibbstone, NJ).
To prepare the BAL T cells, they were placed in glass dishes at 37°C in 5% CO2 for 1 h. The nonadherent cells were gently collected and used as BAL T cells, and the adherent cells were collected after extensive pipetting and used as aveleolar macrophages (AM). Over 95% of the nonadherent cells were CD3 positive as determined by FACScan (Becton Dickinson, Mountain View, CA), and >97% of the adherent cells were alveolar macrophages as determined by morphology and esterase staining. The total recovered BAL cells were 2.9 ± 1.2 x 107 cells for HP patients compared with 0.3 ± 0.1 x 107 cells obtained from healthy controls. The percent lymphocytes isolated from the BAL were 85.7 [pusmn] 5.2 in HP patients and 11.5 ± 3.8 for normal controls, with an average CD4/CD8 ratio of 0.72 for summer-type HP and 1.85 for farmer’s lung.
Preparation of peripheral blood T cells and monocytes
Heparinized peripheral blood was obtained from every subject before the BAL procedure. To prepare PB T cells, PBMC obtained by Ficoll-Hypaque density centrifugation were suspended in RPMI 1640 medium with 10% FCS and were cultured on glass dishes in 5% CO2 at 37°C for 1 h. The glass-nonadherent cells were gently collected and further depleted of monocytes and B cells by passing them through a nylon-wool column. Finally, the cells were enriched by negative selection using a mixture of mAbs that react against cell type-specific markers on B cells (CD19) and NK cells (CD16), followed by immunomagnetic beads coated with sheep anti-mouse IgG (M450 Dyna-Beads; Dynal AS, Oslo, Norway). This protocol routinely resulted in >98% CD3+ cells. CD4+ and CD8+ T cells were purified from BAL T cells or peripheral T cells by negative selection using anti-CD4 and anti-CD8 Abs and magnetic bead selection. These purified T cells or T cell subsets were resuspended in culture medium (RPMI 1640 containing 10% FCS, 2 ME (10-5 M), 100 U/ml penicillin, and 100 µg/ml streptomycin). The percentage of CD3+ CD4+ or CD3+ CD8+ cell population exceeded 95% as assessed by flow cytometry. Glass-adherent monocytes were removed by intensive pipetting using cold medium (4°C) and were resuspended in culture medium before use.
Cell cultures
BAL T cells and PB T cells were suspended at a cell density of 2 x 106/ml in culture medium and then cultured in a 24-well flat-bottom plate (Costar, Cambridge, MA.). Each well contained 2 x 106 T cells and 2 x 105 AMs or monocytes in 1 ml of culture medium. The cells were stimulated with soluble OKT3 mAb (10 ng/ml) for both BAL T cells and PB T cells, in the presence or the absence of optimal doses of human rIL-10 (10 ng/ml; PharMingen, San Diego, CA), human rIL-12 (5 ng/ml; gift from M. Kobayashi at Genetics Institute, Cambridge, MA), or IL-10 plus IL-12 for 24 or 48 h at 37°C in a humidified atmosphere containing 5% CO2. In some cases cell stimulation was also conducted using immobilized anti-CD3 and anti-CD28 Ab. For those cultures 1 µg of each Ab was added to each well for 2 h at room temperature. The wells were washed with medium before adding the cells. Results obtained using immobilized Ab was identical with those obtained from soluble Ab stimulation, and therefore only data from the soluble Ab experiments are shown. The cell culture supernatants were stored at -20°C before assessment.
Cytokine levels in the cell culture supernatants and BAL fluid
The cytokines in each cell culture supernatant and BAL fluid
were measured by ELISA. Before analysis, BAL fluid was concentrated
10-fold using ultracentrifugation through a Centricon-3 (m.w. cut-off,
3000 Da) membrane. ELISA kits for IL-2, IFN-, IL-12, IL-4, and IL-10
were purchased from R & D Systems (Minneapolis, MN) and PharMingen,
respectively. The lower detection limits of the ELISA kit for each
cytokine were as follows: IL-2, 6.0 pg/ml; IL-4, 10 ng/ml; IL-10, 14
pg/ml; IFN-, 10 pg/ml; and IL-12, 5 pg/ml.
Flow cytometric analysis of surface molecules on BAL cells and peripheral blood cells
Purified BAL T cells (1 x 105), PB T cells, monocytes, and AMs were incubated in 50 µl of staining buffer (PBS containing 2% BSA and 0.05% sodium azide) for 15 min at 4°C in the presence of 1 mg/ml normal human IgG to reduce background binding via Fc receptors expressed on the cell surface. Cells were then incubated with cell-specific mAbs-FITC: CD3, CD4, or CD8 for T cells and CD14 (PharMingen) for monocytes and AM. To evaluate CD80 and CD86 Ag expression on monocytes and AM, an indirect staining method was performed using unlabeled anti-CD80 or anti-CD86 mAb (PharMingen) and FITC-conjugated goat anti-mouse IgG- specific F(ab')2 Ab (PharMingen). Flow cytometric analysis of cell surface markers was performed using FACScan (Becton Dickinson) with CellQuest software. A minimum of 10,000 events were collected for each sample. In all experiments, negative controls consisted of mouse IgG isotype-matched Abs.
Analysis of intracellular cytokine production by flow cytometry
Intracellular cytokines were detected by flow cytometry using a
modification of the methods reported by Jung et al. (30).
Briefly, for each sample, 2 x 106 BAL T
cells or PB T cells, in 1 ml of RPMI 1640 with 10% FBS, were
stimulated with 12-O-tetradecanoylphorbol-13-acetate (TPA)
(10 ng/ml) and A23187 (250 ng/ml) in the presence of brefeldin (2
µM). After 6–8 h of activation, cells were washed in PBS, and the
cell surface was stained with anti-CD4- or
anti-CD8-Quantum Red-conjugated Ab. Then the cells were fixed for
20 min with 2% formaldehyde, washed twice with PBS, and permeabilized
by PBS supplemented with 2% FCS, 2 mM NaN3, and
0.5% saponin. In every case, incubation was conducted at room
temperature. Permeabilized cells were incubated with anti-IL-4-PE
mAb or anti-IL-2-PE mAb and anti-hIFN--FITC mAb in
PBS/FCS/NaN3/saponin. After 30 min of incubation
at room temperature, cells were washed twice with the same buffer,
resuspended in staining buffer (PBS supplemented with 2% FCS and
0.05% NaN3), and analyzed by flow cytometry. The
6–8 h point for these studies was chosen to avoid any side effects due
to long term exposure to monensin, which usually occur by 12 h.
Although this time point may not represent maximal production of all
cytokines, it is sufficient to determine relative production by
peripheral vs lung-derived cells.
RNA analysis by RT-PCR
BAL T cells and PB T cells (2 x 106)
were obtained before and after 24-h stimulation with TPA and A23187.
The cells were washed, and total RNA was extracted using RNA STAT
(Promega, Madison, WI) as recommended by the manufacturer. Reverse
transcriptase reactions to generate cDNA were performed using AMV
reverse transcriptase (Promega). PCR were performed using 1 µg of
cDNA, 0.5 µM oligonucleotide primers (each), 2 mM
MgCl2, and 0.2 mM NTPs in a final reaction volume
of 50 µl. Thirty amplification cycles were performed (1 min at
94°C; 1 min at 55°C; 1.5 min at 72°C). The PCR
primers used in this study are listed below. Following
amplification, a portion of the PCR reactions was electrophoresed on a
1% agarose gel and visualized using ethidium bromide: ß-actin: 5'
primer, 5'-TCATGAAGTGTGACGTTGACATCCGT; 3' primer,
5'-CCTAGAAGCATTTGCGGTGCACGATG; IFN-: 5' primer,
5'-GCTCTGCATCGTTTTTGGGTTCTCTTGGCTG; 3' primer,
5'-CCTTTTTCGCTTCCCTGTTTTAGCTGCTGG; IL-2: 5' primer,
5'-ATGTACAGGATGCAACTCCTGTCTT; 3' primer, 5'-GTCAGTTGTTGAGATGCTTTTGAC;
IL-4: 5' primer, 5'-ATGGGTCTCACCTCCCAACTG; 3' primer,
5'-TCAGCTCGAACACTTTGAATATTTCTCTCTCAT; IL-10: 5' primer,
5'-AAGCTGCGAACCAAGACAGACA T; 3' primer,
5'-AGCTATCCCAGAGCCCCAGATCCGG; and IL-12 RB2: 5' primer, 5'-AGACACCCACTT
ATACACTGAGTA; 3' primer, 5'-AGAGGCACAAACACCAGAAGAAGAG.
Statistical analysis
Data in the table and figures are expressed as the mean ± SD. Statistical analysis was performed using Student’s t test, and a confidence level of p < 0.05 was used.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
To investigate the cytokine profile of T cells obtained from HP
patients, BAL and PB T cells were activated in cell culture by the
addition of TPA and calcium ionophore for 24 h. mRNA was collected
and subjected to RT-PCR analysis for both Th1 and Th2 cytokines. As
shown in Fig. 1
, expression of Th2
cytokines IL-4 and IL-10 and Th1 cytokines IFN- and IL-2 could be
detected for both BAL T cells and PB T cells.
|
To further identify whether there were quantitative protein
differences in particular Th1 or Th2 cytokines, single-cell
intracellular cytokine analysis was performed. Isolated BAL and PB T
cells were stimulated with TPA and a calcium ionophore, A23187, for
6–8 h in the presence of brefeldin. Intracellular cytokine production
by BAL T cells was analyzed at the single cell level, thus allowing for
the use of fresh cells and also to further classify the cell as
CD4+ or CD8+. As shown in
Fig. 2, the percentage of
IFN--producing cells among BAL CD4+ T cells
was significantly higher than that among PB CD4+
T cells. This proportion of IFN--producing cells was approximately
the same for either CD4+ or
CD8+ T cells. Conversely, the percentage of
IL-4-producing cells among BAL CD4+ T cells was
significantly lower than that in PB CD4+ T cells
(Fig. 2). Again, the same ratio was observed for both
CD4+ and CD8+ T cells.
Relative quantitation of the amount of cytokine produced by individual
cells indicated that there was no apparent difference in the
intracellular IL-4 and IFN- cytokine intensity between BAL
CD4+ T cells and PB CD4+ T
cells (data not shown). These results confirm the RT-PCR findings, and
together the data clearly suggests a type 1-dominant profile found in
BAL T, but not PB T, cells of HP individuals.
|
production in BAL
CD4+ T cells and PB CD4+ T cells
In addition to IFN-, another type 1-defining cytokine is IL-2.
We next compared intracellular IL-2 production in stimulated BAL vs PB
T cells. As shown in Fig. 3, there were
significant differences between the two cell populations. The
percentage of IL-2-producing cells among BAL CD4+
T cells of HP patients was significantly less than that observed for PB
CD4+ T cells. In addition, the intracellular IL-2
intensity in BAL CD4+ T cells was significantly
lower than that in PB CD4+ T cells (Fig. 3A). It was uniformly observed for all individuals tested
that a significant percentage of the intracellular IL-2-positive cells
was contained within the CD4+ T population with
only a few percentage contained within the CD8+ T
cell population for both BAL and peripheral cells (Fig. 3A).
These cells were then analyzed in the context of IFN- production.
Interestingly, the majority of the IL-2-producing
CD4+ BAL T cells colocalized with the
IFN--producing cells (Fig. 3B and Table I), while the majority of IL-2-producing
CD4+ PB T cells clustered preferentially with the
T cells not expressing IFN- protein, classified as Th0 cells (Fig. 3B and Table I). This suggests that the predominant
CD4+ T cell type in HP BAL cells can be
classified as highly polarized effector Th1 cells.
|
|
Next we investigated what factor(s) may influence the development
of the observed type 1 cytokine profile of BAL T cells in HP patients.
We speculated that a type 1 cytokine profile might develop as a result
of less BAL T cell production of intrinsic IL-10 and/or more production
of IL-12 following stimulation compared with stimulated blood-derived T
cells. To determine whether this was a contributory factor, we measured
the intrinsic levels of IL-10 in cell culture supernatants of BAL T
cells or PB T cells stimulated with soluble OKT3 Ab (sOKT3) and
cocultured with AM and monocytes, respectively. As shown in Fig. 4, sOKT3-stimulated BAL T cells
cocultured with AM produced significantly less intrinsic IL-10 than PB
T cells cocultured with monocytes. This lower intrinsic IL-10
production by BAL cells may favor the development or polarization of a
type 1 profile for BAL T cells in HP patients. There was no further
increase in IL-10 production when the BAL T cells were stimulated with
TPA and ionophore (data not shown), indicating that these cells were
not capable of producing as much IL-10 as PB T cells even under maximal
stimulatory conditions. In addition, we measured IL-12 levels in the
cell culture supernatants of sOKT-3-stimulated BAL cells and PB T
cells. Both cell types produced detectable amounts of IL-12 (10–20
pg/ml/106 cells), and there was no significant
difference between the two cultures (data not shown).
|
by BAL T cells and PB T
cells of HP patients by IL-10 and IL-12
We next determined whether the addition of either IL-10 or IL-12
could affect IFN- production. BAL T cells or PB T cells were
stimulated with soluble anti-CD3 Ab alone (Fig. 5A) in the presence of
autologous AM or blood monocytes, respectively, or with the addition of
IL-10 (10 ng/ml), IL-12 (10 ng/ml), or a combination of the two
cytokines for 24 h (Fig. 5B). As confirmed in Fig. 5A, IFN- production by BAL T cells was almost twice that
by PB T cells. The addition of IL-10 significantly reduced the relative
percentage of IFN- production by PB T cells (Fig. 5B),
similar to previous reports (22). IL-10 had less of an
effect, although still significant, on IFN- production by BAL T
cells (Fig. 5B). The addition of IL-12 to BAL T cells
induced a significant increase in IFN- production by BAL T cells,
but had no significant effect on PB T cells. A combination of IL-10 and
IL-12 had no effect on BAL T cell generation of IFN-, whereas PB T
cells demonstrated a reduction similar to that with IL-10 alone (Fig. 5B). The inhibitory activity of IL-10 on IFN- production
was specific, as costimulation in the presence of neutralizing
anti-IL-10 Abs abrogated the IL-10 effect. Therefore, both PB and
BAL T cells are responsive to IL-10, although PB cells to a greater
extent than BAL cells. In addition, only BAL T cells are responsive to
IL-12 stimulation. We also investigated the effects of these cytokines
on IL-4 production and determined that IL-4 was produced by both BAL
and PB T cells comparably, and in neither case was IL-4 production
affected by the addition of IL-10 (data not shown). Taken together,
these results demonstrate that BAL T cells of HP patients
preferentially produce IFN- when stimulated with sOKT3 cocultured
with AM even in the presence of IL-10. Conversely, IL-10 significantly
suppressed the production of IFN- by sOKT3-stimulated PBT cells
cocultured with monocytes.
|
The cultures used to generate the previous data contained AM and
blood-derived monocytes. These accessory cells have been shown to play
a role in the effect of IL-10 on IL-12 production and therefore on
IFN- production (31). The difference in the responses
of BAL and PB T cells to IL-10 might indicate that the difference
resides in the accessory cells. To investigate this possibility we
first determined whether there was a phenotypic difference in the
expression of either B7-1 (CD80) or B7-2 (CD 86), membrane proteins
shown to influence T cell cytokine development (22).
Alveolar macrophages and blood monocytes were isolated from HP patients
and assessed for surface expression of either B7-1 or B7-2. As shown in
Fig. 6, 70–80% of cells derived from
either the lung or the periphery were positive for B7-2. There was
similarly no difference between AM or monocytes for B7-1 expression,
although only 20–30% of the cells were positive for B7-1 expression
(Fig. 6). There was no difference in the B7-1 or B7-2 expression on AM
between HP patients and normal controls (data not shown). These data
indicate that B7-1 or B7-2 expression was probably not involved in the
preferential Th1 cell development seen in HP patients.
|
in
sOKT3-stimulated PB T cells
With no difference in the expression of B7-1 and B7-2 molecules
for AMs and monocytes, we next investigated whether there was a
functional difference between the two and assessed the potential of AM
to influence IFN- production by PB T cells. In these experiments PB
T cells were purified to >97% by negative selection. Plastic adherent
enriched autologous AM or peripheral blood monocytes (2 x
105/well) were added to the PB T cell cultures
and stimulated with sOKT3 Ab for 24 h. Both the AM and monocytes
were added at a ratio of 9:1 T cells to AM to duplicate the average
ratio seen in peripheral blood. The cultures received either IL-10 (10
ng/ml) or IL-10 plus IL-12 (10 ng/ml). As shown in Fig. 7, IFN- production by sOKT3-stimulated
PBT cocultured with AMs was suppressed with IL-10 to a similar degree
as PB T cells cocultured with monocytes. The presence of IL-12 was
unable to reverse the IL-10-induced suppression of IFN- production
(Fig. 7). These results suggest that in this culture system AM from HP
patients are not functionally different from blood-derived monocytes
obtained from the same individual, and that the lack of a response by
BAL T cells to IL-10 stimulation is not due to a phenotypic difference
in the AM.
|
Regulation of IFN- production by T cells is facilitated in part
by the relative amounts of IL-10 and IL-12. To date we have observed
that BAL T cells generate less IL-10 than PB T cells under the same
stimulating conditions. We have also observed that PB T and BAL T cells
generate comparable levels of IL-12. Interestingly, IFN- production
by PB T cells is not affected by stimulation with exogenously added
IL-12, while BAL T cells demonstrate significant increases. To
investigate this difference we next determined the expression level of
the IL-12R. Optimal binding of IL-12 requires expression of the ß,
high affinity, component of the IL-12R (IL-12Rß2). IL-12Rß2 levels
were examined in unstimulated PB and BAL T cells by RT-PCR. As shown in
Fig. 8, BAL T cells contained message for
IL-12Rß2, while PB T cells had no detectable message. This finding
would support the observed difference in PB vs BAL T cells in
generating IFN- following IL-12 stimulation and, in combination with
the findings that BAL T cells produce less IL-10, could provide a
mechanism by which BAL T cells in HP are influenced to develop a Th1
profile.
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
is
required for development of HP, as IFN- knockout mice are resistant
to development of the disease. In vitro studies have demonstrated that
modulation of IFN- is accomplished primarily by a change in the
ratio of IL-10 and IL-12 present in the culture system. Stimulation by
IL-10, through several different mechanisms (31, 32, 33) acts
to reduce production of IFN-. Conversely, stimulation by IL-12
results in augmentation of IFN- production by T cells
(34). Consistent with these findings, HP animal models
have demonstrated that increases in IL-12 result in an amplification of
the severity of HP, while the presence of IL-10 ameliorates the disease
(35, 36). It is unclear at present whether this same
paradigm exists in humans and what mechanism(s) contributes to
development of the predominantly Th1 profile.
In this study we examined the production of Th1 and Th2 cytokines by
BAL T cells and PB T cells of HP patients. The results of intracellular
cytokine detection at the single-cell level yielded several interesting
findings. Intracellular cytokine analysis by flow cytometry clearly
demonstrated a Th1-dominant profile in BAL CD4+ T
cells and CD8+ T cells. Although Th1 cytokines
(IFN-) were present in PB T cells, the percentage of positive cells
was only 30% of that seen in BAL cells. When a correlation between
IFN--producing cells and cells producing IL-2 was examined, it was
determined that there was a significantly lower percentage of BAL
CD4+ T cells producing IL-2 compared with PB
CD4+ T cells. Our data would suggest that while
development of HP appears to be dependent on the Th1 cytokine IFN-,
it does not correlate with the production of another Th1 cytokine,
IL-2. These findings are consistent with studies by Semenzato and
coworkers (19), who reported that no IL-2 mRNA was
expressed in resting BAL T cells from HP patients and, in addition,
with previous work from this laboratory (29), indicating
that both BAL CD4+ and CD8+
T cells had decreased expression of IL-2 mRNA and produced
significantly lower IL-2 when these cells were stimulated with TPA and
A23187 compared with PB T cells. It has been suggested that IL-2 is
more appropriately regarded as a marker of a precursor Th cell rather
than a Th1 cell, and that cells that primarily produce IFN- or IL-4
which have developed from precursor Th CD4+ T
cells should be designated effector Th1 or Th2 cells, respectively
(37). Therefore, our data would suggest that PB T cells of
HP patients are comprised of Th0, Th1, and Th2 cell types but are
predominantly Th2-like, while BAL T cells from the same patients are
Th1-like and, further, that the Th1-like CD4+ BAL
T cells of HP patients can be considered polarized effector Th1
cells.
With regard to IL-4 production, the percentage of IL-4-producing CD4+ and CD8+ T cells was significantly lower than that seen in PB T cells; however, in absolute numbers, a significant number of IL-4-producing T cells was found in the lungs of HP patients. If IL-4-producing T cells, in addition to other IL-4-producing cells such as mast cells (38), persist in the lung for a sufficient period of time, they may contribute to the fibrotic scarring of the lung of HP patients.
A major factor that usually influences the development of either a Th1 or a Th2 cytokine profile is the local cytokine environment, in particular the ratio of IL-10 to IL-12. A predominance of IL-10 favors Th2 development, while IL-12 favors Th1 expansion (34). In BAL cells stimulated with anti-CD3 Ab, we observed a significant decrease in IL-10 production compared with stimulated PMBCs. The decrease in IL-10 production could be a result of a variety of factors. Monocytic cells cannot only serve as a major source of IL-10 (39), but they can stimulate the production of IL-10 by T cells. As monocytic cells were present in the cultures, their contribution to IL-10 production was investigated. There was no difference in expression of either costimulatory molecules CD80 (B7-1) or CD86 (B7-2) on AMs of HP patients compared with blood-derived monocytes, indicating that the difference in production was not due to the ability of the monocytic cells to stimulate T cell IL-10 production. Monocytic cells also did not appear to be a source of IL-10, as culturing AMs with PB T cells resulted in comparable levels of IL-10 as those seen with monocytes and PB T cells. Therefore, it appears that the lack of IL-10 production seen in the BAL cell cultures could not be attributed to a difference in the monocytic cells, but, rather, was due to a difference in the T cells’ ability to generate the cytokine. These cells demonstrated an inability to generate as much IL-10 as PB T cells even when stimulated with TPA and ionomycin. The lack of IL-10 production was not the result of a generalized suppression, as production of IL-12 was comparable to that in PB T cells.
The source of increased T cells in the lung, in general, is due to recruitment of peripheral T cells rather than to clonal expansion within the lung (40). This, however, has not been addressed specifically in HP-related inflammation, although it raises the possibility that once peripheral T cells are recruited to the lung, regulatory mechanisms associated with HP exist within the lung that reduce the capacity of the recruited cell to produce IL-10. The reduction in IL-10 production by the BAL T cells probably contributes to the development of the Th1-dominant cytokine profile. Unfortunately, direct ELISA measurement of IL-10 contained within BAL fluid has been difficult to achieve for both normal subjects and HP patients.
Another contributory factor to the development of the Th1 profile is
the effect of IL-12. Comparable levels of IL-12 were detected in both
the BAL and PB T cell cultures; however, the addition of IL-12 to BAL T
cells resulted in a significant increase in IFN- production, while
there was no change in production by PB T cells. Stimulation by IL-12
can be regulated by either the amount of IL-12 present or the state of
the IL-12R. High affinity IL-12 binding and signaling can only be
achieved by expression of the ß-chain of the IL-12 R, which creates a
high affinity complex. No ß-chain message could be detected in PB T
cells, whereas it was easily detected in BAL T cells. Interestingly,
the IL-12 high affinity receptor has been shown to be preferentially
expressed on Th1 cells (41, 42). The presence of the high
affinity receptor complex on the Th1 subset could account for the
differential response by the two T cell groups following addition of
IL-12 and probably contributes to the overall development and expansion
of Th1 cells in association with HP.
In summary, these studies demonstrate for the first time that the
increase in CD4+ and CD8+ T
cells into the lungs of individuals with HP have a predominantly Th1
cytokine profile. There is a significant increase in IFN-
production; however, this is distinct from IL-2 production. Consistent
with this Th1 profile, BAL T cells were unable to generate comparable
IL-10 levels as seen with PB T cells from the same patients, and BAL T
cells had detectable and functional high affinity IL-12R, whereas PB T
cells lacked the message for the high affinity ß-chain. Our
findings suggest that HP in humans, as has been reported in animal
models, is a Th1-mediated disease, similar to sarcoidosis, and that
development of this disease may be associated with changes in IL-10
production and IL-12R expression by T cell recruited to the lung.
Although our data demonstrating a Th1-type response were evident for
all HP patients studied, we were limited in the number of patients we
could recruit, and therefore, further studies are required to confirm
our findings.
|
Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Hisato Yamasaki, First Department of Internal Medicine, Kumamoto University School of Medicine, Honjo 1-1-1, Kumamoto 860-0811, Japan.
3 Abbreviations used in this paper: HP, hypersensitivity pneumonitis; BAL T, T cells obtained from bronchoalveolar lavage fluid; PB T, peripheral blood-derived T cells; AM, aveleolar macrophages; TPA, 12-O-tetradecanoylphorbol-13-acetate; sOKT3, soluble OKT3.
Received for publication April 14, 1999. Accepted for publication June 28, 1999.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
is necessary for the expression of hypersensitivity pneumonitis. J. Clin. Invest. 99:2386.[Medline]
production by suppressing natural killer cell stimulatory factor/interleukin-12 synthesis in accessory cells. J. Exp. Med. 178:1041.This article has been cited by other articles:
|
|
 |
|
  P. L. Simonian, C. L. Roark, F. Wehrmann, A. M. Lanham, W. K. Born, R. L. O'Brien, and A. P. Fontenot IL-17A-Expressing T Cells Are Essential for Bacterial Clearance in a Murine Model of Hypersensitivity Pneumonitis J. Immunol., May 15, 2009; 182(10): 6540 - 6549. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. L. Simonian, C. L. Roark, F. Wehrmann, A. K. Lanham, F. Diaz del Valle, W. K. Born, R. L. O'Brien, and A. P. Fontenot Th17-Polarized Immune Response in a Murine Model of Hypersensitivity Pneumonitis and Lung Fibrosis J. Immunol., January 1, 2009; 182(1): 657 - 665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Ye, Y. Dalavanga, N. Poulakis, S. U. Sixt, J. Guzman, and U. Costabel Decreased expression of haem oxygenase-1 by alveolar macrophages in idiopathic pulmonary fibrosis Eur. Respir. J., May 1, 2008; 31(5): 1030 - 1036. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Barrera, F. Mendoza, J. Zuniga, A. Estrada, A. C. Zamora, E. I. Melendro, R. Ramirez, A. Pardo, and M. Selman Functional Diversity of T-Cell Subpopulations in Subacute and Chronic Hypersensitivity Pneumonitis Am. J. Respir. Crit. Care Med., January 1, 2008; 177(1): 44 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Korosec, K. Osolnik, I. Kern, M. Silar, K. Mohorcic, and M. Kosnik Expansion of Pulmonary CD8+CD56+ Natural Killer T-Cells in Hypersensitivity Pneumonitis Chest, October 1, 2007; 132(4): 1291 - 1297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Hwang, S. Kim, W. S. Park, and D. H. Chung IL-4-Secreting NKT Cells Prevent Hypersensitivity Pneumonitis by Suppressing IFN-{gamma}-Producing Neutrophils J. Immunol., October 15, 2006; 177(8): 5258 - 5268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Pawliczak, C. Logun, P. Madara, J. Barb, A. F. Suffredini, P. J. Munson, R. L. Danner, and J. H. Shelhamer Influence of IFN-{gamma} on gene expression in normal human bronchial epithelial cells: modulation of IFN-{gamma} effects by dexamethasone Physiol Genomics, September 21, 2005; 23(1): 28 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Chen, Z. Tong, Q. Ye, S. Nakamura, U. Costabel, and J. Guzman Expression of tumour necrosis factor receptors by bronchoalveolar cells in hypersensitivity pneumonitis Eur. Respir. J., June 1, 2005; 25(6): 1039 - 1043. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Facco, L. Trentin, L. Nicolardi, M. Miorin, E. Scquizzato, D. Carollo, I. Baesso, M. Bortoli, R. Zambello, G. Marcer, et al. T cells in the lung of patients with hypersensitivity pneumonitis accumulate in a clonal manner J. Leukoc. Biol., May 1, 2004; 75(5): 798 - 804. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-R. Blanchet, E. Israel-Assayag, and Y. Cormier Inhibitory Effect of Nicotine on Experimental Hypersensitivity Pneumonitis In Vivo and In Vitro Am. J. Respir. Crit. Care Med., April 15, 2004; 169(8): 903 - 909. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Pardo, K. M. Smith, J. Abrams, R. Coffman, M. Bustos, T. K. McClanahan, J. Grein, E. E. Murphy, A. Zlotnik, and M. Selman CCL18/DC-CK-1/PARC up-regulation in hypersensitivity pneumonitis J. Leukoc. Biol., October 1, 2001; 70(4): 610 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Chen, B. M. Greenlee, M. Wills-Karp, and D. R. Moller Attenuation of Lung Inflammation and Fibrosis in Interferon-{gamma}-Deficient Mice after Intratracheal Bleomycin Am. J. Respir. Cell Mol. Biol., May 1, 2001; 24(5): 545 - 555. [Abstract] [Full Text]
|
|
|
|
|
|
J. Todt, J. Sonstein, T. Polak, G. D. Seitzman, B. Hu, and J. L. Curtis Repeated Intratracheal Challenge with Particulate Antigen Modulates Murine Lung Cytokines ,2 J. Immunol., April 15, 2000; 164(8): 4037 - 4047. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
